NobukoHijiyaMD

Pediatric Hematology & Oncology • New York, NY

Professor Columbia University Medical Center

Overview of Dr. Hijiya

Dr. Nobuko Hijiya is a pediatric hematologist and oncologist based in New York, NY. She completed her medical education and training at NYU Grossman School of Medicine and Memorial Sloan-Kettering Cancer Center, specializing in pediatric hematology and oncology. She was an attending physician at St. Jude Children's Research Hospital and Ann & Robert H Lurie Children's Hospital of Chicago/Northwestern University and is at Columbia University Medical Center. Dr. Hijiya's expertise includes leukemia, lymphoma, and pediatric cancers. Her recent publications focus on topics related to chronic myeloid leukemia, chemotherapy-induced nausea management, and innovative treatments for pediatric leukemia. Dr. Hijiya has been involved in clinical trials assessing treatments for acute lymphoblastic leukemia, chronic myelogenous leukemia, and relapsed/refractory pediatric leukemia.

Office
161 Fort Washington Avenue
New York, NY 10032
Book by Phone+1(231) 787-0963

Education & Training

NYU Grossman School of MedicineResidency, Pediatrics, 1998 - 1999
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1995 - 1998
Memorial Sloan-Kettering Cancer CenterClass of 1998, MD
Memorial Sloan-Kettering Cancer CenterClass of 1998, MD
NYU Grossman School of MedicineResidency, Pediatrics, 1994 - 1995

Certifications & Licensure

NY State Medical License 1997 - 2026
IL State Medical License 2007 - 2020
TN State Medical License 2001 - 2008
NJ State Medical License 1999 - 2001
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

A Study of the Safety and Preliminary Efficacy of Oral Midostaurin (PKC412) in Relapsed or Refractory Pediatric Leukemia Start of enrollment: 2009 Sep 01
Terminated
Phase 1, Phase 2
T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) Start of enrollment: 2009 Jul 10
Terminated
Phase 2
A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Apr 14
Completed
Phase 1
Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission Start of enrollment: 2012 Feb 21
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

9 citations
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ayse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, Yuan Chang, Adrian Levine
The Lancet. Oncology. 2024-05-01
Pediatric oncology provider perspectives and patient/family perceptions of chemotherapy-induced nausea and vomiting management: Experiences at an academic medical center.
Hadley Bloomhardt, Melissa Rubin, Yanling Xue, Zhezhen Jin, Laura Masino
Pediatric Blood & Cancer. 2024-04-01
1 citations
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach.
Jenna M Menger, Ryan S Sathianathen, Kathleen M Sakamoto, Nobuko Hijiya
Current Oncology Reports. 2024-03-01

Press Mentions

Treatment of Patients with Advanced Chronic Myeloid LeukemiaOctober 5th, 2019

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO Platinum
Coventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Multiplan PHCS PPO
Multiplan PPO
Sagamore Health Plus
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment